Johnson & Johnson Pvt Ltd’s baby powder production licence was revoked by Maharashtra’s Food and Drugs Administration (FDA) on Friday “in the interest of the general public health.”
The state government agency stated in a release that Johnson’s Baby Powder may have an impact on a newborn baby’s skin.
During a lab test, samples of the baby powder did not meet the required pH level, according to the regulator.
According to the press release, the action was taken in response to a conclusive report from the Central Drugs Laboratory in Kolkata, which found that “the sample does not conform to IS 5339:2004 with respect to the test for pH.”
For quality control, the FDA reportedly obtained Johnson’s Baby Powder samples from Nashik and Pune.
The samples were deemed to be “not of the standard quality” by the government analyst because they failed to meet the test pH requirements of IS 5339:2004 for skin powder for newborns, according to the statement.
The FDA then instructed Johnson and Johnson to recall the stock of the aforementioned product from the market and issued a show-cause notice to the corporation in accordance with the Drugs Cosmetics Act 1940 and Rules, according to the announcement.
The company “didn’t accept the findings” of the government analyst and contested its legality in court, it was noted. The report was sent to the Central Drugs Laboratory.